Evolution of the role of the transplant pharmacist on the multidisciplinary transplant team

American Journal of Transplantation

Volumn 11, Issue 8, 2011, Pages 1576-1583

  Alloway, R R ^a   Dupuis, R ^b   Gabardi, S ^c,d   Kaiser, T E ^a   Taber, D J ^e   Tichy, E M ^f   Weimert Pilch, N A ^e  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c Department of Transplant Surgery and Pharmacy Services ^*  (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^f YALE NEW HAVEN HOSPITAL   (United States)

Author keywords

Multidisciplinary; pharmacist; pharmacy; role; transplant

Indexed keywords

ACCREDITATION; EDUCATION; HOSPITAL DEPARTMENT; HUMAN; MEDICAL SOCIETY; PHARMACIST; PHARMACY; PRIORITY JOURNAL; PROFESSIONAL PRACTICE; RESPONSIBILITY; REVIEW; STANDARDIZATION; TRAINING; TRANSPLANTATION;

HUMANS; ORGAN TRANSPLANTATION; PATIENT CARE TEAM; PHARMACISTS; PROFESSIONAL ROLE;

EID: 79961027942     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2011.03601.x     Document Type: Review

References (33)

1. Mitchell JF,. Pharmacist involvement as a member of a renal transplant team. Am J Hosp Pharm 1976; 33: 55-58.
2. Jones RA, Lopez LM, Beall DG,. Cost-effective implementation of clinical pharmacy services in an ambulatory care clinic. Hosp Pharm 1991; 26: 778-782.
3. Peterson CD, Lake KD,. Reducing prophylactic antibiotic costs in cardiovascular surgery: the role of the clinical pharmacist. Drug Intell Clin Pharm 1986; 20: 134-137. (Pubitemid 16146049)
4. Miyagawa CI, Rivera JO,. Effect of pharmacist interventions on drug therapy costs in a surgical intensive-care unit. Am J Hosp Pharm 1986; 43: 3008-3013. (Pubitemid 17214143)
5. Hatoum HT, Hutchinson RA, Witte KW, Newby GP,. Evaluation of the contribution of clinical pharmacists: inpatient care and cost reduction. Drug Intell Clin Pharm 1988; 22: 252-259.
6. Bertch KE, Hatoum HT, Willett MS, Witte KW,. Cost justification of clinical pharmacy services on a general surgery team: focus on diagnosis-related group cases. Drug Intell Clin Pharm 1988; 22: 906-911.
7. Chrischilles EA, Helling DK, Aschoff CR,. Effect of clinical pharmacy services on the quality of family practice physician prescribing and medication costs. DICP 1989; 23: 417-421. (Pubitemid 19139281)
8. Mueller BA, Abel SR,. Impact of college of pharmacy-based educational services within the hospital. DCIP 1990; 24: 422-425. (Pubitemid 20138020)
9. Garrelts JC, Smith DF Jr,. Clinical services provided by staff pharmacists in a community hospital. Am J Hosp Pharm 1990; 47: 2011-2015. (Pubitemid 20326447)
10. Thornton JP, Goff DA, Segal R, Guy JT,. Impact of a clinical pharmacist on antibiotic prescribing. A multicenter trial. J Pharm Technol 1991; 7: 195-200.
11. Taylor JT, Kathman MS,. Documentation of cost savings from decentralized clinical pharmacy services at a community hospital. Am J Hosp Pharm 1991; 48: 1467-1470.
12. Haig GM, Kiser LA,. Effect of pharmacist participation on a medical team on costs, charges, and length of stay. Am J Hosp Pharm 1991; 48: 1457-1462.
13. Torok N, Brown G,. The economic impact of clinical pharmacists' unsolicited recommendations. Hosp Pharm 1992; 27: 1056-1058.
14. Chuang LC, Sutton JD, Henderson GT,. Impact of a clinical pharmacist on cost saving and cost avoidance in drug therapy in an intensive care unit. Hosp Pharm 1994; 29: 215-218. (Pubitemid 24081745)
15. Montazeri M, Cook DJ,. Impact of a clinical pharmacist in a multidisciplinary intensive care unit. Crit Care Med 1994; 22: 1044-1048. (Pubitemid 24182740)
16. Anonymous. The United Network of Organ Sharing Bylaws. Attachment 1 to Appendix B of the UNOS Bylaws; Designated Transplant Program Criteria. UNOS-Appendix B-Attachment I-XIII-1-91.
17. [UNOS] United Network for Organ Sharing. 2007. Attachment 1 to Appendix B of UNOS Bylaws: designated transplant program criteria. Available at. Accessed November 6, 2009.
18. Anonymous. Department of Health and Human Services, Centers for Medicare & Medicaid Services 42 CFR Parts 405, 482, 488, and 498 Medicare Program; Hospital Conditions of Participation: Requirements for Approval and Re-Approval of Transplant Centers To Perform Organ Transplants; Final Rule. Federal Register 2007; 72 (61): 15197-15279.
19. Anonymous. Title 42 of the Public Health Service Act. Part 121-Organ Procurement and Transplantation Network. Washington, D.C. Sections 215, 371-376 of the Public Health Service Act (42 U.S.C. 216, 273-274d); sections 1102, 1106, 1138 and 1871 of the Social Security Act (42 U.S.C. 1302, 1306, 1320b-8 and 1395hh); and section 301 of the National Organ Transplant Act, as amended (42 U.S.C. 274e).
20. Immunology/Transplantation Practice and Research Network (PRN) history report. 2009. Available at. Accessed November 6, 2009.
21. Required Educational Outcomes G, and Objectives for Postgraduate Year Two (PGY2) Pharmacy Residencies in Solid Organ Transplant. Bethesda, MD: American Society of Health-System Pharmacists, 2008. Available at. Accessed September 10, 2009.
22. De Bleser L, Matteson M, Dobbels F, Russell C, De Geest S,. Interventions to improve medication-adherence after transplantation: a systematic review. Transplant Int 2009; 22: 780-797.
23. De Geest S, Dobbels F, Fluri C, Paris W, Troosters T,. Adherence to the therapeutic regimen in heart, lung, and heart-lung transplant recipients. J Cardiovasc Nurs 2005; 20: S88-S98.
24. Denhaerynck K, Dobbels F, Cleemput I, et al,. Prevalence, consequences, and determinants of nonadherence in adult renal transplant patients: a literature review. Transplant Int 2005; 18: 1121-1133. (Pubitemid 41726755)
25. Dobbels F, Ruppar T, De Geest S, Decorte A, Van Damme-Lombaerts R, Fine RN,. Adherence to the immunosuppressive regimen in pediatric kidney transplant recipients: a systematic review. Pediatr Transplant 2010; 14: 603-613.
26. Horn E, and, Jacobi J,. The critical care clinical pharmacist: evolution of an essential team member. Crit Care Med 2006; 34: S46-S51. (Pubitemid 43255751)
27. Burckart GJ,. Transplant pharmacy: 30 years of improving patient care. Ann Pharmacother 2007; 41: 1261-1263. (Pubitemid 47122566)
28. Martin JE, Zavala EY,. The expanding role of the transplant pharmacist in the multidisiplinary practice of transplantation. Clin Transplant 2004; 2004: 50-54. (Pubitemid 39214098)
29. Chisholm MA, Mulloy LL, Lagadeesan M, DiPiro JT,. Impact of clinical pharmacy services on renal transplant patients' compliance wiht immunosuppressive medications. Clin Transplant 2001; 15: 330-336. (Pubitemid 32936880)
30. Chisholm MA, Mulloy LL, Jagadeesan M, Martin BC, DiPiro JT,. Effect of clinical pharmacy services on the blood pressure of African-American renal transplant patients. Ethn Dis 2002; 12: 392-397.
31. Wang HY, Chan ALF, Chen MT, Liao CH, Tian YF,. Effects of pharmaceutical care intervention by clinical pharmacists in renal transplant clinics. Transplant Proc 2008; 40: 2319-2323.
32. Ciminelli AM, Dupuis R, Williams D,. Patient education role of a pharmacist on a transplant service. Am J Health Syst Pharm 2000; 57: 767-768. (Pubitemid 30220021)
33. Costanzo MR, Dipchand A, Starling R, et al,. The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients. J Heart Lung Transplant 2010; 29: 914-956.